The estimated Net Worth of Timothy J O Shea is at least $647 ezer dollars as of 14 December 2021. Mr. Shea owns over 500 units of Cutera Inc stock worth over $38,777 and over the last 21 years he sold CUTR stock worth over $407,739. In addition, he makes $199,989 as Independent Director at Cutera Inc.
Sign up
Mr. Shea CUTR stock SEC Form 4 insiders trading
Timothy has made over 9 trades of the Cutera Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently he bought 500 units of CUTR stock worth $17,585 on 14 December 2021.
The largest trade he's ever made was exercising 10,000 units of Cutera Inc stock on 4 November 2005 worth over $141,400. On average, Timothy trades about 1,323 units every 196 days since 2004. As of 14 December 2021 he still owns at least 56,199 units of Cutera Inc stock.
You can see the complete history of Mr. Shea stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Timothy O'Shea biography
Timothy J. O'Shea is an Independent Director of Cutera, Inc. Mr. O’Shea was with OXO Capital from 2008 to 2014 serving as managing director. From 1995 to 2008, he served in a variety of management positions at Boston Scientific, including Corporate Vice President of Business Development from 2000 to 2008. Mr. O’Shea currently acts as an advisor to several medical device companies. Mr. O’Shea holds a B.A. in history from the University of Detroit.
What is the salary of Timothy Shea?
As the Independent Director of Cutera Inc, the total compensation of Timothy Shea at Cutera Inc is $199,989. There are 6 executives at Cutera Inc getting paid more, with David Mowry having the highest compensation of $3,154,020.
How old is Timothy Shea?
Timothy Shea is 67, he's been the Independent Director of Cutera Inc since 2004. There are no older and 10 younger executives at Cutera Inc.
What's Timothy Shea's mailing address?
Timothy's mailing address filed with the SEC is C/O CUTERA, INC., 3240 BAYSHORE BLVD., BRISBANE, CA, 94005.
Insiders trading at Cutera Inc
Over the last 21 years, insiders at Cutera Inc have traded over $58,122,420 worth of Cutera Inc stock and bought 1,064,292 units worth $26,108,997 . The most active insiders traders include Kevin P Connors, J Daniel Plants és David A Gollnick. On average, Cutera Inc executives and independent directors trade stock every 22 days with the average trade being worth of $13,243. The most recent stock trade was executed by Michael Karavitis on 14 May 2024, trading 63,603 units of CUTR stock currently worth $165,368.
What does Cutera Inc do?
cutera was established in the san francisco bay area (brisbane) in 1998 by veteran laser and optical engineers. as the pioneer of nd:yag technology, cutera® is the trusted authority in face + body energy-based medical aesthetic technologies that practitioners around-the-world turn to for innovation, sophistication and performance. at cutera, we’re always looking forward; developing new solutions, products and industry-leading services designed around the needs of medical aesthetic community—delivering better results, faster and safer than ever before. cutera’s premium portfolio of products include: xeo®, trusculpt® and excel v™. in 2014, cutera introduced two new exciting additions to their family of premium products: excel hr™ for high-speed, comfortable, hair removal and enlighten™, the industry’s first picosecond + nanosecond + 2 wavelength high-powered laser system. today, our worldwide presence is represented in 40 countries, with direct operations in north america, france, austra
What does Cutera Inc's logo look like?
Complete history of Mr. Shea stock trades at Cutera Inc
Cutera Inc executives and stock owners
Cutera Inc executives and other stock owners filed with the SEC include:
-
David Mowry,
Chief Executive Officer, Director -
R. Jason Richey,
President -
David H. Mowry,
CEO & Director -
Rohan Seth,
Chief Financial Officer -
Gregory Barrett,
Independent Director -
J. Daniel Plants,
Independent Chairman of the Board -
Timothy O'Shea,
Independent Director -
Joseph Whitters,
Independent Director -
Katherine Zanotti,
Independent Director -
J. Daniel Plants,
Exec. Chairman -
Anne Werdan,
Director - Investor Relations -
Darren Alch,
Vice President, General Counsel, Secretary -
Rohan Seth,
Chief Financial Officer -
Dr. Michael Karavitis,
Exec. VP & Chief Technology Officer -
Jerry P Widman,
Director -
Miguel Pardos,
EVP, International Sales -
James A. Reinstein,
President and CEO -
Clinton Severson,
Director -
David B Apfelberg,
Director -
Larry Laber,
EVP, North America Sales -
Kevin P Connors,
President and CEO -
David A Gollnick,
VP of Research and Development -
Thomas John Liolios,
VP of International -
Keith J Sullivan,
Director -
Nicholas Sheridan Lewin,
Director -
Sandra A. Gardiner,
EVP & Chief Financial Officer -
Elisha W Finney,
Director -
Guy P Nohra,
Director -
Michael J Levernier,
VP of Clinical Development -
Associates Iii Lp Medventure,
10% owner -
Guy Palta California Partne...,
-
Kathleen A Maynor,
VP of Regulary Affairs & QA -
Associates Management Iii C...,
10% owner -
Guy Palta Partnersalta Cali...,
-
Dean Macfarland,
-
Michael W Sasnett,
-
W Mark Lortz,
Director -
Leonard C De Benedictis,
Chief Technology Officer -
White Annette Campbell,
Director -
Robert John Jr Shine,
VP of International -
Ronald J Santilli,
CFO & VP of Finance and Admin. -
John Connors,
VP of North American Sales -
Jeryl L Hilleman,
Director -
Michael Karavitis,
EVP, Chief Technology Officer -
Sheila Hopkins,
Director -
Juliane Park,
Director -
Janet D. Widmann,
Director -
Kevin J Cameron,
Director -
Stuart Drummond,
Interim CFO -
Taylor C. Harris,
Chief Executive Officer -
Jeffrey S Jones,
Chief Operating Officer -
Stephana Eilene Patton,
Chief Legal Officer